LITTLETON, Colo., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development ...

Collegium Pharmaceutical (COLL) came out with quarterly earnings of $1.61 per share, missing the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.34 per share a year ago.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Don't miss out on the headlines from Stockhead. Followed categories will be added to My News. In this episode, host Fraser Palamara dissects the $6 million raising completed today by biotech ...

Featured here, the Balance Sheet for Vivos Therapeutics Inc, which summarises the company's financial position including assets, liabilities and shareholder equity for each of the latest 10 period ...

Just last week, Vivo unveiled the Vivo X200 series of flagship smartphones in its home market of China. These devices pack cutting edge technology and various AI powered features. But now, the ...

https://www.tipranks.com/news/the-fly/curaleaf-price-target-lowered-to-c6-50-from-c11-at-alliance-global-partners Monopar Therapeutics Inc ( (MNPR)) just unveiled an ...

vivo unveiled the X200 series last week. It includes the X200, X200 Pro, and X200 Pro mini. The vivo X200 and X200 Pro went on sale in China last week, and now, the X200 Pro mini is also available ...

Viking Therapeutics (NASDAQ:VKTX) added ~18% on Thursday to reach a five-month high as Wall Street focused on updates on its obesity candidate VK2735, even as the company posted better-than ...

Inhibikase Therapeutics ( (IKT)) has shared an update. Inhibikase Therapeutics, Inc. has secured approximately $110 million through a private placement, boosting its potential financing to $275 ...